Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02212561
Brief Title: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

First Submitted : July 30, 2014
First Submitted that Met QC Criteria : August 7, 2014
First Posted : August 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 1, 2017
Last Update Posted : March 3, 2017